PRIDERX Trademark

Trademark Overview


On Wednesday, April 30, 2025, a trademark application was filed for PRIDERX with the United States Patent and Trademark Office. The USPTO has given the PRIDERX trademark a serial number of 99163015. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, December 17, 2025. This trademark is owned by PrideRx LLC. The PRIDERX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Telemedicine marketing platform that connects patients to physicians and pharmacies
priderx

General Information


Serial Number99163015
Word MarkPRIDERX
Filing DateWednesday, April 30, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, December 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTelemedicine marketing platform that connects patients to physicians and pharmacies
Pseudo MarkPRIDE RX

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, April 30, 2025
Primary Code035
First Use Anywhere DateSaturday, January 27, 2024
First Use In Commerce DateSaturday, January 27, 2024

Trademark Owner History


Party NamePrideRx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75225

Trademark Events


Event DateEvent Description
Wednesday, April 30, 2025NEW APPLICATION ENTERED
Wednesday, April 30, 2025APPLICATION FILING RECEIPT MAILED
Thursday, September 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 19, 2025ASSIGNED TO EXAMINER
Wednesday, December 17, 2025NON-FINAL ACTION WRITTEN
Wednesday, December 17, 2025NON-FINAL ACTION E-MAILED
Wednesday, December 17, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED